The ATS Foundation Research Program Benefit is the premier networking reception held during the ATS International Conference. It attracts international leaders across the respiratory spectrum, and is a key source of unrestricted research grants the Foundation awards to young investigators in pulmonary, critical care, and sleep medicine.

For more information on benefit academic medical institution, nonprofit organization, or individual group packages, please contact Ally Felix at

For more information on corporate packages, please contact Lara Endreszl, Corporate Alliances Assistant Manager.

We offer two ways to participate:

  • Reserved seating ensures your group has its own space, as well as network the event.
  • Unreserved seating allows you entry to the benefit, but your seating is not reserved.

You can register for the benefit with your ATS 2020 registration when conference registration opens early December.

The ATS Foundation thanks Genentech and GSK for their support at the Sapphire Level for the 11th Annual ATS Foundation Research Program Benefit; Mylan Inc., and Theravance Biopharma at the Crystal Level; Sanofi Genzyme-Regeneron, Mallinckrodt and Novartis at the Gold Level; Sunovion Pharmaceuticals, Inc, Freeman, Gilead Sciences, Inc., Vertex, Boehringer Ingelheim, Insmed and AstraZeneca at the Silver Level; Ascend Integrated Media, NBRC and Sunovion Pharmaceuticals, Inc at the Bronze Level.

The ATS Foundation also thanks the many individuals and medical institutions that have stepped forward to support the Research Program and young investigators in pulmonary, critical care, and sleep medicine.